Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey.

Horváth I, Canotilho M, Chlumský J, Chorostowska-Wynimko J, Corda L, Derom E, Ficker JH, Kneussl M, Miravitlles M, Sucena M, Thabut G, Turner AM, van 't Wout E, McElvaney NG.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00171-2018. doi: 10.1183/23120541.00171-2018. eCollection 2019 Feb.

2.

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests.

Topalovic M, Das N, Burgel PR, Daenen M, Derom E, Haenebalcke C, Janssen R, Kerstjens HAM, Liistro G, Louis R, Ninane V, Pison C, Schlesser M, Vercauter P, Vogelmeier CF, Wouters E, Wynants J, Janssens W; Pulmonary Function Study Investigators.

Eur Respir J. 2019 Feb 14. pii: 1801660. doi: 10.1183/13993003.01660-2018. [Epub ahead of print]

PMID:
30765505
3.

Comparison of ERS'93 to the newly published GLI'17 reference values for carbon monoxide transfer factor.

Oostveen E, Derom E, Vints AM, Liistro G.

Respir Med. 2019 Jan;146:113-115. doi: 10.1016/j.rmed.2018.12.005. Epub 2018 Dec 15.

PMID:
30665508
4.

Development of a complex intervention for early integration of palliative home care into standard care for end-stage COPD patients: A Phase 0-I study.

Scheerens C, Chambaere K, Pardon K, Derom E, Van Belle S, Joos G, Pype P, Deliens L.

PLoS One. 2018 Sep 19;13(9):e0203326. doi: 10.1371/journal.pone.0203326. eCollection 2018.

5.

Launching Global Lung Function Initiative reference values in Belgium: tips and tricks.

Derom E, Liistro G, Oostveen E, Marchand E, Bedert L, Peché R, Janssens W; Pulmonary Function Working Group of the Belgian Thoracic Society.

Eur Respir J. 2018 Aug 2;52(2). pii: 1800922. doi: 10.1183/13993003.00922-2018. Print 2018 Aug. No abstract available.

PMID:
30072542
6.

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice.

Cataldo D, Derom E, Liistro G, Marchand E, Ninane V, Peché R, Slabbynck H, Vincken W, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 5;13:2089-2099. doi: 10.2147/COPD.S164259. eCollection 2018. Review.

7.

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D.

Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.

PMID:
29914940
8.

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies.

LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 1;13:1819-1831. doi: 10.2147/COPD.S161489. eCollection 2018.

9.

How resources determine pulmonary rehabilitation programs: A survey among Belgian chest physicians.

Janssens W, Corhay JL, Bogaerts P, Derom E, Frusch N, Dang DN, Kibanda J, Ruttens D, Thyrion L, Troosters T, Marchand E.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318767732. doi: 10.1177/1479972318767732. Epub 2018 Apr 9.

10.

Cardiac Autonomic Function and Reactivity Tests in Physically Active Subjects with Moderately Severe COPD.

Mohammed J, Derom E, De Backer T, De Wandele I, Calders P.

COPD. 2018 Feb;15(1):51-59. doi: 10.1080/15412555.2017.1412414. Epub 2018 Jan 5.

PMID:
29303373
11.

Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.

De Backer E, Gremonprez F, Brusselle G, Depuydt P, Van Dorpe J, Van Haverbeke C, Goeminne PC, Derom E.

Acta Clin Belg. 2018 Dec;73(6):413-417. doi: 10.1080/17843286.2017.1420521. Epub 2017 Dec 29.

PMID:
29287518
12.

Evidence for aerobic exercise training on the autonomic function in patients with chronic obstructive pulmonary disease (COPD): a systematic review.

Mohammed J, Derom E, Van Oosterwijck J, Da Silva H, Calders P.

Physiotherapy. 2018 Mar;104(1):36-45. doi: 10.1016/j.physio.2017.07.004. Epub 2017 Jul 22. Review.

PMID:
28947079
13.

Autonomic symptoms in patients with moderate and severe chronic obstructive pulmonary disease.

Mohammed J, Derom E, De Wandele I, Rombaut L, Calders P.

Acta Clin Belg. 2018 Jun;73(3):182-190. doi: 10.1080/17843286.2017.1379255. Epub 2017 Sep 22. Erratum in: Acta Clin Belg. 2018 Jun;73(3):236.

PMID:
28934906
14.

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).

Kemp SV, Slebos DJ, Kirk A, Kornaszewska M, Carron K, Ek L, Broman G, Hillerdal G, Mal H, Pison C, Briault A, Downer N, Darwiche K, Rao J, Hübner RH, Ruwwe-Glosenkamp C, Trosini-Desert V, Eberhardt R, Herth FJ, Derom E, Malfait T, Shah PL, Garner JL, Ten Hacken NH, Fallouh H, Leroy S, Marquette CH; TRANSFORM Study Team *.

Am J Respir Crit Care Med. 2017 Dec 15;196(12):1535-1543. doi: 10.1164/rccm.201707-1327OC.

PMID:
28885054
15.

Structural changes in the COPD lung and related heterogeneity.

Copot D, De Keyser R, Derom E, Ionescu C.

PLoS One. 2017 May 25;12(5):e0177969. doi: 10.1371/journal.pone.0177969. eCollection 2017.

16.

Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.

Usmani OS, Molimard M, Gaur V, Gogtay J, Singh GJP, Malhotra G, Derom E.

Clin Pharmacokinet. 2017 Oct;56(10):1139-1154. doi: 10.1007/s40262-017-0524-6. Review.

17.

A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.

Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, Ninane V, Peché R, Pilette C, Vincken W, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:601-613. doi: 10.2147/COPD.S124459. eCollection 2017.

18.

Efficacy of tiotropium-olodaterol fixed-dose combination in COPD.

Derom E, Brusselle GG, Joos GF.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 13;11:3163-3177. doi: 10.2147/COPD.S92840. eCollection 2016. Review.

19.
20.

The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).

Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 4;11:193-205. doi: 10.2147/COPD.S95055. eCollection 2016.

21.

Evidence for Autonomic Function and Its Influencing Factors in Subjects With COPD: A Systematic Review.

Mohammed J, Meeus M, Derom E, Da Silva H, Calders P.

Respir Care. 2015 Dec;60(12):1841-51. doi: 10.4187/respcare.04174. Epub 2015 Oct 20. Review.

22.

Effects of Whole Body Vibration in Patients With COPD.

Salhi B, Malfait TJ, Van Maele G, Joos G, van Meerbeeck JP, Derom E.

COPD. 2015;12(5):525-32. doi: 10.3109/15412555.2015.1008693. Epub 2015 Aug 4.

PMID:
26457458
23.

New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.

Ninane V, Vandevoorde J, Cataldo D, Derom E, Liistro G, Munghen E, Peché R, Schlesser M, Verleden G, Vincken W.

Respir Med. 2015 Nov;109(11):1430-8. doi: 10.1016/j.rmed.2015.09.013. Epub 2015 Sep 30. Review.

24.

Airways resistance and specific conductance for the diagnosis of obstructive airways diseases.

Topalovic M, Derom E, Osadnik CR, Troosters T, Decramer M, Janssens W; Belgian Pulmonary Function Study Investigators.

Respir Res. 2015 Jul 22;16:88. doi: 10.1186/s12931-015-0252-0.

25.

Hot Topics in Noninvasive Ventilation: Report of a Working Group at the International Symposium on Sleep-Disordered Breathing in Leuven, Belgium.

Vrijsen B, Chatwin M, Contal O, Derom E, Janssens JP, Kampelmacher MJ, Muir JF, Pinto S, Rabec C, Ramsay M, Randerath WJ, Storre JH, Wijkstra PJ, Windisch W, Testelmans D.

Respir Care. 2015 Sep;60(9):1337-62. doi: 10.4187/respcare.03796. Epub 2015 Jun 30.

26.

Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalities.

Salhi B, Haenebalcke C, Perez-Bogerd S, Nguyen MD, Ninane V, Malfait TL, Vermaelen KY, Surmont VF, Van Maele G, Colman R, Derom E, van Meerbeeck JP.

Lung Cancer. 2015 Aug;89(2):167-74. doi: 10.1016/j.lungcan.2015.05.013. Epub 2015 May 22.

27.

Author correction. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Fležar M, Hébert J, McGarvey L, Pizzichini E, Reid J, Veale A, Grönke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E.

Eur Respir J. 2015 Jun;45(6):1763. doi: 10.1183/09031936.50136014. No abstract available.

28.

The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.

Beeh KM, Westerman J, Kirsten AM, Hébert J, Grönke L, Hamilton A, Tetzlaff K, Derom E.

Pulm Pharmacol Ther. 2015 Jun;32:53-9. doi: 10.1016/j.pupt.2015.04.002. Epub 2015 May 6.

29.

Activity of the alpha-1 antitrypsin deficiency registry in Belgium.

Hutsebaut J, Janssens W, Louis R, Willersinn F, Stephenne X, Sokal E, Derom E.

COPD. 2015 May;12 Suppl 1:10-4. doi: 10.3109/15412555.2015.1021916.

30.

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Fležar M, Hébert J, McGarvey L, Pizzichini E, Reid J, Veale A, Grönke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E.

Eur Respir J. 2015 Apr;45(4):969-79. doi: 10.1183/09031936.00136014. Epub 2015 Jan 8. Erratum in: Eur Respir J. 2015 Jun;45(6):1763.

31.

Testing spirometers: are the standard curves of the american thoracic society sufficient?

Lefebvre Q, Vandergoten T, Derom E, Marchandise E, Liistro G.

Respir Care. 2014 Dec;59(12):1895-904. doi: 10.4187/respcare.02918. Epub 2014 Sep 2.

32.

The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients.

Salhi B, Huysse W, Van Maele G, Surmont VF, Derom E, van Meerbeeck JP.

Lung Cancer. 2014 Apr;84(1):56-61. doi: 10.1016/j.lungcan.2014.01.011. Epub 2014 Jan 23.

PMID:
24560331
33.

Contribution of four common pulmonary function tests to diagnosis of patients with respiratory symptoms: a prospective cohort study.

Decramer M, Janssens W, Derom E, Joos G, Ninane V, Deman R, Van Renterghem D, Liistro G, Bogaerts K; Belgian Pulmonary Function Study Investigators.

Lancet Respir Med. 2013 Nov;1(9):705-13. doi: 10.1016/S2213-2600(13)70184-X. Epub 2013 Oct 4.

PMID:
24429274
34.

Exercise intolerance in heart failure: update on exercise parameters for diagnosis, prognosis and therapeutic interventions.

Pardaens S, Calders P, Derom E, De Sutter J.

Acta Cardiol. 2013 Oct;68(5):495-504. Review.

PMID:
24283111
35.

Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease.

Hohlfeld JM, Sharma A, van Noord JA, Cornelissen PJ, Derom E, Towse L, Peterkin V, Disse B.

J Clin Pharmacol. 2014 Apr;54(4):405-14. doi: 10.1002/jcph.215. Epub 2013 Nov 27.

36.

Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial.

Charususin N, Gosselink R, Decramer M, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, van Helvoort H, Heijdra Y, Klaassen M, Glöckl R, Kenn K, Langer D.

BMJ Open. 2013 Aug 5;3(8). pii: e003101. doi: 10.1136/bmjopen-2013-003101.

37.

Spirometric reference values for an East-African population.

Musafiri S, van Meerbeeck JP, Musango L, Derom E, Brusselle G, Joos G, Rutayisire C.

Respiration. 2013;85(4):297-304. doi: 10.1159/000337256. Epub 2012 May 11.

38.

Technical assessment of spirometers connected in series.

Lefebvre Q, Vandergoten T, Derom E, Marchandise E, Liistro G.

Respir Care. 2012 Aug;57(8):1273-7. doi: 10.4187/respcare.01464. Epub 2012 Feb 17.

39.

Increased interoceptive awareness in fear of flying: sensitivity to suffocation signals.

Vanden Bogaerde A, Derom E, De Raedt R.

Behav Res Ther. 2011 Jun;49(6-7):427-32. doi: 10.1016/j.brat.2011.03.011. Epub 2011 Apr 7.

PMID:
21561600
40.

Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resection.

Holvoet T, van Meerbeeck JP, Van De Wiele C, Salhi B, Derom E.

Lung Cancer. 2011 Nov;74(2):212-8. doi: 10.1016/j.lungcan.2011.03.001. Epub 2011 Apr 9.

PMID:
21481964
41.

Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.

Xu J, Nave R, Lahu G, Derom E, Derendorf H.

J Clin Pharmacol. 2010 Oct;50(10):1118-27. doi: 10.1177/0091270009354994. Epub 2010 Feb 11.

PMID:
20150524
42.

Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot Study.

Salhi B, Demedts I, Simpelaere A, Decraene S, Vermaelen K, Surmont V, van Meerbeeck JP, Derom E.

Rehabil Res Pract. 2010;2010:481546. doi: 10.1155/2010/481546. Epub 2010 Aug 5.

43.

Effects of pulmonary rehabilitation in patients with restrictive lung diseases.

Salhi B, Troosters T, Behaegel M, Joos G, Derom E.

Chest. 2010 Feb;137(2):273-9. doi: 10.1378/chest.09-0241. Epub 2009 Oct 26.

PMID:
19858229
44.

Assessment of respiratory mechanical properties with constant-phase models in healthy and COPD lungs.

Ionescu C, Derom E, De Keyser R.

Comput Methods Programs Biomed. 2010 Jan;97(1):78-85. doi: 10.1016/j.cmpb.2009.06.006. Epub 2009 Jul 22.

PMID:
19628290
45.

Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.

Derom E, Louis R, Tiesler C, Engelstätter R, Kaufman JM, Joos GF.

Eur Respir J. 2009 Jun;33(6):1277-86. doi: 10.1183/09031936.00079908. Epub 2009 Jan 22. Erratum in: Eur Respir J. 2009 Sep;34(3):783. Dosage error in article text.

46.

Primary care spirometry.

Derom E, van Weel C, Liistro G, Buffels J, Schermer T, Lammers E, Wouters E, Decramer M.

Eur Respir J. 2008 Jan;31(1):197-203. doi: 10.1183/09031936.00066607. Review.

47.

Pulmonary rehabilitation in chronic obstructive pulmonary disease.

Derom E, Marchand E, Troosters T.

Ann Readapt Med Phys. 2007 Oct;50(7):615-26, 602-14. Epub 2007 May 21. Review. English, French.

PMID:
17559963
48.

Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.

Derom E, Strandgården K, Schelfhout V, Borgström L, Pauwels R.

Respir Med. 2007 Sep;101(9):1931-41. Epub 2007 Jun 1.

49.

Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma.

Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A.

Eur Respir J. 2007 May;29(5):871-8. Epub 2007 Jan 24.

50.

Supplemental Content

Support Center